Congressional Stock Trades & Disclosures
Thomas H. Kean, Jr. is a U.S. Representative, a Republican representing NJ. As of November 2026, Quantellect has tracked 196 disclosed stock trades across 69 companies, representing $3.2M in disclosed transaction value, each filed publicly under the STOCK Act.

Trading summary
Thomas H. Kean, Jr.
- Member Score
- 81Strong
- Estimated profit results · 2Y
- Member Score rank
- #15 of 74
- Profitability rank · by return %: #26 of 74
- Profit win rate (2Y)
- 70%
- 40 of 57 priced buys up · unrealized
- vs S&P 500 (2Y)
- +6.5%
- +$31K estimated excess profit
- Latest disclosed trade
- Sell · MSFT
- Traded 27 OCT 2026 · Disclosed 19 NOV 2026
About Thomas H. Kean, Jr.'s congressional trading
Since January 2023, Representative Thomas H. Kean, Jr., the New Jersey Republican who represents the state's 7th District, has filed reports containing 178 disclosed securities transactions under the Stop Trading on Congressional Knowledge Act. Quantellect's current published congressional roster contains 539 sitting members; 276 have no disclosed trades in the transaction record (237 House members and 39 senators). Kean is not one of them. The annual transaction count rose from 30 in 2023 to 35 in 2024 and 59 in 2025; the 2026 record contains 54 transactions through the most recent filing.
The composition of that activity has shifted year to year. In 2023, sales outnumbered purchases 14 to 9, with 7 transactions categorized as other rounding out the year. That reversed in 2024, when purchases led 17 to 5, and again in 2025, when purchases outpaced sales 34 to 22. In 2026, the pattern flipped back toward selling, with 33 sales against 21 purchases through the most recent disclosures. Of all 178 transactions, 177 carry a “Self” attribution and one carries a spousal attribution. The disclosures therefore attribute nearly all of the activity to Kean, with one spouse-attributed exception; the “Self” code identifies the filer relationship but does not establish who selected or executed a transaction.
Sector Concentration and Frequently Disclosed Names
Health care is the dominant theme in Kean's disclosures, accounting for 37 of the transactions tallied by sector, ahead of financials at 28, an unclassified “Unknown” bucket at 24, industrials at 22, information technology at 18, communication services at 16, consumer discretionary at 12, materials at 11, energy at 3, real estate at 3, consumer staples at 2, and a separately tracked “technology” category at 2.
Stryker Corporation, the Michigan-based medical technology company known for surgical equipment, orthopedic implants and its Mako robotic-assisted surgery products, is the single most frequently disclosed security, appearing in 12 transactions, every one of them a sale. Johnson & Johnson, the New Brunswick, New Jersey pharmaceutical and medical technology company, follows with 8 transactions, also all sales. That pairing, one Michigan medical-technology company and one based in Kean's home state, forms one of the clearer patterns in the filings: both securities appear repeatedly in sales, with no disclosed purchases in the transaction record.
Financials tell a more mixed story. Markel Corporation and S&P Global appear in 5 and 4 transactions respectively, all sales. First Citizens BancShares appears in 5 transactions split between 3 purchases and 2 sales, making it a name for which the record contains both transaction types. Amazon.com stands out on the buy side: all 5 of its disclosed transactions are purchases, with no Amazon sales in the record. Analog Devices, Check Point Software Technologies and nVent Electric each show a mix of purchases and sales across 4 transactions apiece, while Alphabet's Class A shares and Microsoft appear 4 times each, weighted toward sales in both cases. Two other securities disclosed three times each are worth noting for their one-directional transaction records: ESAB Corporation, the welding and cutting-equipment manufacturer, and EQT Corporation, the Appalachian natural gas producer, each show 3 purchases and no sales. The latest transaction date supplied for both is July 7, 2026.
The Latest Disclosures and What the Companies Do
Kean's most recent filing, dated August 18, 2026, reports self-attributed transactions executed from July 7 through July 22, 2026, and continues several of the patterns above. It reports partial sales of Stryker and Alphabet's Class A shares on July 22. For July 8, it reports purchases of Amazon.com and Toast, Inc., the Boston-based restaurant-technology company whose cloud platform handles point-of-sale, payments and back-office operations for restaurants. It also reports purchases of ESAB and EQT on July 7, giving each security a third disclosed purchase and no sales in the record. Each transaction in this filing carries a disclosed amount range of $1,001 to $15,000.
The filing immediately prior, dated July 15, 2026, includes transactions executed from June 1 through June 30. Among its late-June entries are partial sales of Analog Devices, Johnson & Johnson, Markel and S&P Global, two purchases of ESAB, a partial sale of Alphabet and a purchase of a U.S. Treasury Note. Treasury Note purchases recur elsewhere in the transaction history on October 17 and December 31, 2025, twice on February 18, 2026, and again on May 4 and June 17, 2026. The disclosures identify those instruments as government securities, distinguishing them from the stock transactions reported alongside them.
Further back, the record shows repeated purchase-only activity in names like Amcor, the Zurich-based packaging manufacturer; Canadian Pacific Kansas City, the freight railway; and Danaher, the diagnostics and life-sciences instruments company. Each appears in multiple purchases without a sale in the disclosed transaction data. On the sale side, Franklin Resources, the asset manager, and Oracle each show more sales than purchases across their disclosed transactions. A filing dated January 16, 2026, also reports exchange transactions executed on December 16, 2025, in Liberty Live Holdings' Series A and Series C shares. Liberty Live is described in the data as a live-entertainment company, and an exchange is categorized separately from an outright purchase or sale.
Quantellect's current published Member Score for Thomas H. Kean, Jr. is 81 out of 100, in the “strong” tier, ranked 15 of 74 measured members, with coverage classified as “covered”.
Disclosure Notes and Attribution
This profile is built from Kean's official Periodic Transaction Reports filed with the Clerk of the House, as required under the Stop Trading on Congressional Knowledge Act of 2012. Members of Congress must disclose transactions in stocks, bonds and other securities within specific reporting windows; the House Committee on Ethics' financial disclosure instruction guide sets out the reporting rules, including the amount ranges rather than exact dollar figures used throughout these filings and the codes used to attribute a transaction to the member, a spouse or a dependent.
Of the 178 transactions in this record, 177 carry a “Self” attribution and one carries a spousal attribution; none are attributed as joint, attributed to a dependent child, or left unattributed. Dollar amounts throughout are disclosed ranges, not exact figures, under the reporting rules. The securities discussed above are included solely because they appear in transaction-level disclosures, which record purchases, sales, exchanges and other reportable events rather than providing a complete inventory of assets.
Trading activity
Estimated trading profits
The 2Y view uses the same buy-only, priced trade inputs as the Member Score.
Based on 75 of 84 disclosed buys with pricing coverage.
Jan 18, 2023 to Nov 20, 2026
No priced buy disclosures in this window.
Based on 3 of 3 disclosed buys with pricing coverage.
Aug 20, 2026 to Nov 20, 2026
Based on 14 of 14 disclosed buys with pricing coverage.
May 20, 2026 to Nov 20, 2026
Based on 22 of 26 disclosed buys with pricing coverage.
Nov 20, 2025 to Nov 20, 2026
Based on 57 of 63 disclosed buys with pricing coverage.
Nov 21, 2024 to Nov 21, 2026
Based on 69 of 76 disclosed buys with pricing coverage.
Nov 20, 2023 to Nov 20, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Where the Money Sits
share of disclosed trades · top sectors
Periodic Transaction Report filings
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
MSFTMicrosoft Corporation | Sell | $15,001 - $50,000 | 27 OCT 2026 | $531.33 | -8.81% |
SYKStryker Corporation | Sell | $1,001 - $15,000 | 27 OCT 2026 | $301.42 | +2.85% |
JNJJohnson & Johnson | Sell | $1,001 - $15,000 | 27 OCT 2026 | $268.73 | +0.65% |
U.S. Treasury Note | Buy | $50,001 - $100,000 | 20 OCT 2026 | — | — |
WBDWarner Bros Discovery Inc | Sell | $1,001 - $15,000 | 07 OCT 2026 | $30.95 | +0.00% |
WBDWarner Bros Discovery Inc | Sell | $1,001 - $15,000 | 07 OCT 2026 | $30.95 | +0.00% |
JNJJohnson & Johnson | Sell | $1,001 - $15,000 | 30 SEP 2026 | $264.74 | +2.16% |
SYKStryker Corporation | Sell | $1,001 - $15,000 | 30 SEP 2026 | $275.39 | +12.57% |
ESABESAB Corp | Buy | $1,001 - $15,000 | 29 SEP 2026 | $67.48 | +10.76% |
MDLZMondelez International Inc | Sell | $1,001 - $15,000 | 23 SEP 2026 | $61.44 | +7.88% |
Latest congress trades we've covered
- Ted Cruz disclosed a $250,001 - $500,000 Goldman Sachs Group Inc sell
- Thomas H. Kean, Jr. disclosed a $15,001 - $50,000 Microsoft Corporation sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Stryker Corporation sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Johnson & Johnson sell
- Steve Cohen disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Michael A. Rulli disclosed a $1,001 - $15,000 NVIDIA Corporation sell
- Terri A. Sewell disclosed a $1,001 - $15,000 Tapestry Inc sell
- Michael A. Rulli disclosed a $1,001 - $15,000 Lumentum Holdings Inc sell
Thomas H. Kean, Jr. congressional trading FAQ
Can Thomas H. Kean, Jr. legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Thomas H. Kean, Jr.'s disclosures so the public can review them.
Where does Quantellect get Thomas H. Kean, Jr.'s trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Thomas H. Kean, Jr.'s stock trades?
Quantellect tracks every stock trade Thomas H. Kean, Jr. discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Thomas H. Kean, Jr. disclosed?
Quantellect has tracked 196 disclosed trades by Thomas H. Kean, Jr. across 69 companies.
Which stocks does Thomas H. Kean, Jr. trade most?
Thomas H. Kean, Jr.'s most frequently disclosed positions are SYK (14 disclosed trades), JNJ (11 disclosed trades), MSFT (6 disclosed trades), ABT (5 disclosed trades), AMZN (5 disclosed trades), and FCNCA (5 disclosed trades), followed by GOOGL, MKL, ADI, and AMCR. The full list of companies and individual filings is shown on this page.
Which sectors does Thomas H. Kean, Jr. invest in?
Healthcare is the heaviest sector in Thomas H. Kean, Jr.'s classified disclosures, covering 43 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.
What was Thomas H. Kean, Jr.'s most recent stock disclosure?
Thomas H. Kean, Jr. most recently sold Microsoft Corporation (MSFT) in October 2026, according to public STOCK Act filings tracked by Quantellect.
What is Thomas H. Kean, Jr.'s Quantellect Member Score?
Thomas H. Kean, Jr. has a Quantellect Member Score of 81 out of 100 (Strong). The score ranks members by the estimated unrealized results of their disclosed buys over the last 24 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.
How much has Thomas H. Kean, Jr. made trading stocks?
Quantellect estimates Thomas H. Kean, Jr.'s disclosed buys show an estimated unrealized loss of $5,719 over the trailing 12 months, based on priced disclosed buy transactions through November 20, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.







